z-logo
open-access-imgOpen Access
Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
Author(s) -
Francesco Ferrara,
Raffaele La Porta,
Priscilla Santilli,
Vilma D’Aiuto,
Antonio Vitiello
Publication year - 2020
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/ijp.ijp_417_20
Subject(s) - medicine , covid-19 , multiple sclerosis , coronavirus , respiratory system , intensive care medicine , virology , immunology , disease , outbreak , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here